Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study
The DOI matches its Crossref record.
Abstract
BACKGROUND: This study aimed to quantify the direct medical cost of treating inflammatory bowel disease (IBD) in Manitoba in 2005/2006. METHODS: In all, 7375 individuals with IBD recorded in the University of Manitoba IBD Epidemiology Database were matched on age, gender, and geography to up to 10 non-IBD controls. Data for cases and controls were extracted from Manitoba Health databases in fiscal 2005/2006 for pharmaceutical, physician claims, and hospital abstracts. The mean and median expenditure were computed for the annual cost of pharmaceuticals, hospitalizations (day surgery and inpatient), and physician office visits. We assessed costs based on age, gender, type of IBD, disease duration, and level of care provided. RESULTS: In 2005/2006 the mean direct cost of an IBD case was $3896 (standard error [SE] = $90) which was twice that of controls (P < 0.05). Crohn's disease (CD; n = 3735) was significantly more costly on average than ulcerative colitis (UC; n = 3640) ($4232; SE = $137 and $3552; SE = $117, respectively, P < 0.001). The most costly cases included those within 1 year of diagnosis ($6611; SE = $593), those hospitalized overnight (15%) ($13,495, SE = $416; max = $130,332), those who had a surgical stay (2% of IBD cases) ($18,749, range = $13,413-$125,912), and those using infliximab (0.7%) ($31,440, SE = $2311; max = $96,328). For individuals using infliximab their direct annual average healthcare cost was $9683 (SE = $1745, Max = $55,208) prior to using infliximab. CONCLUSIONS: In Manitoba the direct average annual healthcare cost of CD is greater than UC and that of a patient using infliximab tends to be greater than one incurring a surgical stay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Windsor, J. W., & Kaplan, G. G. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0705-6 · Cited by 320
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
Rocchi, A., Benchimol, E. I., Bernstein, C. N., Bitton, A., Feagan, B., Panaccione, R., Glasgow, K. W., Fernandes, A., & Ghosh, S. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/984575 · Cited by 286
Self-citationMao, E. J., Hazlewood, G. S., Kaplan, G. G., Peyrin‐Biroulet, L., & Ananthakrishnan, A. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13847 · Cited by 245
Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000579 · Cited by 144
“…inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA) share several epidemiologic and clinical features (Pugliatti et al. 2002; Health Canada, 2003; Alamanos et al. 2006; Canadian Institute for Health Information, 2007; Logan & Bowlus, 2010; Bernstein et al. 2012).”
BackgroundSelf-citationParra, R. S., Chebli, J. M., Amarante, H. M., Flores, C., Parente, J. M., Ramos, O., Fernandes, M., Rocha, J. J., Feitosa, M. R., Feres, O., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i38.5862 · Cited by 92
Distance management of inflammatory bowel disease: systematic review and meta-analysis
Huang, V. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i3.829 · Cited by 75
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
Nguyen, G. C., Targownik, L. E., Singh, H., Benchimol, E. I., Bitton, A., Murthy, S. K., Bernstein, C. N., Lee, K., Cooke-Lauder, J., & Kaplan, G. G. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy051 · Cited by 44
Self-citation
Metadata
- Authors
- Bernstein, C. N., Longobardi, T., Finlayson, G., & Blanchard, J. F.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08
- Volume
- 18
- Issue
- 8
- Pages
- 1498-1508
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2082916124
- Cited by
- 87
- References
- 0
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.